Analysis of existing COVID-19 vaccines development and manufacture scaleup suggest that it could be until September 2023 before there are enough doses of a successful vaccine for the whole world, according to findings by the Center for Global Development (CDG).
People wearing protective face masks wait for vaccine trials at Abu Dhabi National Exhibition Centre in Abu Dhabi. (Reuters)
A medic of the regional hospital receives Russia's Sputnik-V vaccine shot against the coronavirus disease (COVID-19) in Tver. (Reuters)
#AstraZeneca resumes the US trial of its experimental #COVID19 vaccine after approval by US regulators, the company confirms. The trial was paused on September 6 after a report of a serious neurological illness in a participant in the company’s UK trial.https://t.co/P0Wqo2gfqA— Al Arabiya English (@AlArabiya_Eng) October 24, 2020